Get started
Author

Alessandra Cucinella

Observed names: A. Cucinella, Cucinella, Alessandra
ORCID: 0000-0003-1277-3986
Observed ORCID: 0000-0003-1277-3986
OpenAlex ID: A5044328241
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge
2021 · M. Bono, D. Fanale, et al. · ESMO Open · 73
PDF
Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?
2022 · Daniele Fanale, Lidia Rita Corsini, et al. · Critical Reviews in Oncology/Hematology · 37
Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome
2021 · Daniele Fanale, Alessia Fiorino, et al. · Frontiers in Oncology · 27
PDF
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay
2023 · Lorena Incorvaia, Gaetana Rinaldi, et al. · Therapeutic Advances in Medical Oncology · 19
The importance of integrated therapies on cancer: Silibinin, an old and new molecule
2024 · Elisa Roca, Giuseppe Colloca, et al. · Oncotarget · 17
Challenges and advances for the treatment of renal cancer patients with brain metastases: From immunological background to upcoming clinical evidence on immune-checkpoint inhibitors
2021 · Lorena Incorvaia, Giorgio Madonia, et al. · Critical Reviews in Oncology/Hematology · 12
Immunometabolic predictive factors in Merkel cell carcinoma (MCC) patients treated with avelumab.
2022 · Giuseppe Badalamenti, Lorena Incorvaia, et al. · Journal of Clinical Oncology · 5
Safety and effectiveness of gemcitabine for the treatment of classic Kaposi’s sarcoma without visceral involvement
2022 · Giuseppe Badalamenti, Lorena Incorvaia, et al. · Therapeutic Advances in Medical Oncology · 4
247P Population-based testing for hereditary breast and ovarian cancer in a cohort of 1,346 patients from Southern Italy (Sicily): When historical background affects genetics
2020 · D. Fanale, L. Incorvaia, et al. · Annals of Oncology · 3
PDF
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in metastatic melanoma patients?
2019 · Daniele Fanale, Lorena Incorvaia, et al. · Journal of Clinical Oncology · 2
267P: Personality profiling in patients with thoracic neoplasia: A different look to change our mindset
2025 · E. Roca, F. Lombardo, et al. · Journal of Thoracic Oncology · 1
PDF
32P Can circulating immune checkpoints and KIT exon 11 mutations be prognostic factors in metastatic gastrointestinal stromal tumors?
2021 · C. Brando, D. Fanale, et al. · Annals of Oncology · 1
20P Is evaluation of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) mutational status on circulating tumour DNA (ctDNA) by liquid biopsy ready for prime-time? A systematic review and an individual patient meta-analysis
2021 · L. Castellana, V. Gristina, et al. · Annals of Oncology · 1
Brain Metastatic Lung Cancer Patients: A Multitarget Therapeutic-Supportive Strategy with Anti-STAT3 Silibinin
2025 · Elisa Roca, Elena Roca, et al. · NeuroSci
PDF
167P Role of the multi-gene panel testing for detection of pathogenic variants in patients with hereditary bilateral breast cancer
2021 · C. Filorizzo, D. Fanale, et al. · Annals of Oncology
1543P Gemcitabine in classic Kaposi’s sarcoma: A pilot study
2021 · G. Badalamenti, L. Incorvaia, et al. · Annals of Oncology
PDF
502P Impact of different selection approaches for identifying Lynch syndrome-related colorectal cancer patients
2021 · D. Fanale, A. Dimino, et al. · Annals of Oncology
PDF
P33.15 TMB in the First-Line Setting of NSCLC: A Systematic Review with Indirect Comparisons Between PD-1 and PD-L1 Inhibitors
2021 · V. Gristina, A. Galvano, et al. · Journal of Thoracic Oncology
PDF
1281P The prognostic impact of tissue tumour mutational burden (TMB) in the first-line treatment of advanced non-oncogene addicted non-small cell lung cancer (NSCLC): A systematic review and meta-analysis of randomized controlled trials
2020 · V. Gristina, A. Galvano, et al. · Annals of Oncology
Hereditary Breast and Ovarian Cancer Syndrome: Frequency and Distribution of Brca1/2 Pathogenic Variants in Sicilian Population
2019 · D. Cancelliere, Alessia Pivetti, et al.
Molecular Analysis of Brca1/2 Genes and Multigene-panel Testing in Sicilian Triple Negative Breast Cancer
2019 · Marco Bono, Nadia Barraco, et al.
Works count: 23
Citation count: 202
H-index: 6
I10-index: 6
Year
Topic
Type